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Abstract 
Primary melanoma of the oral cavity is extremely uncommon tumour consisting approximately 0.2 - 8.0% of all 
melanoma cases and 0.5% of all oral malignancies. It has an aggressive behaviour and poor prognosis, with 5 – 
year - survival rate between 5 - 20%. The initial symptoms are often unnoticed, which lead to late diagnosis and 
worsening of the prognosis. Because of its infrequent occurrence, there is no well - defined classification and 
therapeutic protocol, in contrast to melanomas of another side. Early diagnosis and treatment are essentially 
linked to survival rate. We present a case of palatal melanoma in a 76 – year - old female patient, as we want to 
emphasise the importance of the early detection and accurate diagnosis of melanoma of oral cavity, to its 
influence of the therapeutic outcome. 
 
 
 
 
 
 
 
 
Introduction 
 
Primary melanoma of the oral cavity is 
extremely uncommon tumour consisting 
approximately 0.2 - 8.0% of all melanoma cases and 
0.5% of all oral malignancies [1][2]. It has been called 
“a silent killer”, because of its highlighted aggressive 
behaviour and early metastatic spread [1][3].  
The main aetiology reason for the pathologic 
proliferation of malignant melanocytes along the 
junction between the epithelial and connective tissues 
is not established yet [3]. Although chronic irritation, 
tobacco, alcohol and formaldehyde exposure have 
been implicated as possible risk factors, it is 
considered that most of the melanomas of oral cavity 
arise de novo [4]. In contrast to cutaneous melanoma, 
no particular precursor lesion has been identified, and 
atypical melanocytic hyperplasia is considered as a 
proliferative phase [2]. Despite blue nevi, dysplastic 
nevi involve the oral cavity extremely rare, most often 
– the palate mucosa [5]. While the hard palate is the 
most common side of affection of melanoma of the 
oral cavity, the buccal mucosa is affected in one-third 
of the cases, as the maxillar gingiva is more frequently 
involved than the mandibular one [3]. Uncommonly, 
the tongue and mouth’s floor could also be affected 
[6]. The onset of the disease is between 40 and 70 
years, with male predominance in gender distribution 
[6].  
The initial symptoms are often unnoticed, 
which lead to late diagnosis and worsening of the 
prognosis [1]. Patients usually seek medical help 
because of bleeding, pain or swelling, which are 
associated with vertical growth phase and progression 
of the disease [6][7]. Furthermore, because of the 
anatomic structure of the oral cavity, bone invasion 
and destruction are commonly seen in cases of 
melanoma of the hard palate [2].  
Surgery is the first choice of treatment which 
often require subsequent reconstruction of the defects 
and advanced cases [3][4]. However, the 5 -year - 
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survival rate in advanced cases with bone destruction 
varies between 5 - 20% and only 6.6% more than five 
years, which emphasise the underhanded aggressive 
nature of this kind of tumours [2][7][8]. 
 
 
Case report 
 
A 76 – year - old Caucasian female patient 
presented with two months history of moderate pain in 
the oral cavity, more pronounced on the left. Patient’s 
history was free of comorbidities and medications, as 
well as of family history for dermatologic diseases. 
The conducted physical examination revealed 
unequally pigmented lesion, composed by nodular 
elements, with sharply demarcated, but irregular 
borders, and partially ulcerated surface, covering 
almost the whole hard palate, more pronounced in 
left. Satellite pigmentations with reticular characteristic 
were also established on the right side of the palate 
(Figure 1. a, b, c). 
 
Figure 1: A, B, C - Clinical manifestation of melanoma of the oral cavity in 76-
year-old female patient 
 
The performed paraclinical blood tests 
established leukocytes (10.15 x 10^9/l) and 
monocytes count (8.8%) in the upper border of the 
normal range, slightly elevated glucose level in serum 
(6.18 mmol/l) and LDL - cholesterol (3.06 mmol/l). 
Imaging diagnostic procedures, including head and 
neck CT, obtained pathological lesion, affecting the 
mucosa, above the left half of palladium durum, 
thickened mucosa of the left maxillar sinus (due to 
palatial outgrowth and lamina perpendicular), 5 - 8 
mm in depth, but the preserved bone structure, 
without a sign of destruction. This pathologic finding 
was also affecting the gingiva, through the alveolar 
border. Enlarged lymph nodes with changes in their 
morphologic structure were also detected - two in left 
(level 2B), measuring approximately 29/40 mm and 
16/24 mm and one in the right (level 2B), measuring 
10/17 mm. Pathological soft - tissue nodule 15 mm in 
size was established, affecting the skin and 
subcutaneous tissue of right cheek. Cutaneous 
papillomatous lesion with benign characteristics was 
observed on left cheek. Abdominal CT examination 
revealed a hiatal hernia, cholelithiasis, a parenchymal 
and cortical cyst in left kidney. Enlarged abdominal 
and pelvic lymph nodes were not detected.  
The diagnosis of palatal melanoma with 
lymph node involvement was made, based on these 
findings. No data for organ metastasis spread was 
presented. Clinically, the patient was staged in IIb 
(Westbury classification) and referred to maxillofacial 
surgery department for palatenectomy and 
subsequent reconstruction of the defect. Lymph node 
dissection was also planned. Patient’s further follow 
up, and postsurgical screening was planned in the 
oncology department.  
 
 
Discussion  
 
Although extremely rare and aggressive in 
behavior, due to rapid hematogenous and lymph node 
metastatic spread, melanoma of the oral cavity could 
be asymptomatic flat macule for a long time (9). 
Because of its infrequent occurrence, there is no well -
defined classification and therapeutic protocol, in 
contrast to melanomas of other side [2][3]. Although 
several authors team have been proposed different 
clinical and histological classification systems, unified 
criteria are not accepted worldwide. Therefore, Lopez 
et al. classified melanoma of the oral cavity, based on 
its clinical appearance into: 1) pigmented nodular 
type, 2) non - pigmented nodular type, 3) pigmented 
macular type, 4) pigmented mixed - type, and 5) non -
pigmented mixed type [8]. Westbury has been 
proposed a clinical classification, similar to that for 
cutaneous melanoma, as follow: I - only primary 
tumor, II - metastasis presented (IIa - adjacent skin 
involved, IIb - regional lymph nodes involved, ab - 
adjacent skin and regional lymph nodes involved) and 
III - metastasis beyond regional lymph nodes [10]. 
According to these classification systems, our patients 
was classified as pigmented nodular type melanoma, 
with regional lymph node involvement. The lack of 
papillary and reticular dermis in oral mucosa, Clark’s 
criteria for invasion, also could not be applied in cases 
of melanoma of the oral cavity [6]. Therefore, the 
classification of the Western Society of Teachers of 
Oral Pathology (WESTOP) have been implicated, 
based on histopathological pattern of the tumor, 
namely: (a) melanoma in situ, limited to the epidermis 
and its junction with the connective tissue; (b) invasive 
melanomas, which extend into the connective tissue 
and (c) melanomas with a combined pattern between 
invasive and in situ [6][11]. The level on invasion is 
determined as an independent predictor of survival, 
while the tumor thickness, vascular invasion, and 
necrosis have no significant influence on survival, as 
predictors of the survival rate, in contrast to cutaneous 
melanoma, which thickness determines the further 
diagnostic and therapeutic behavior in one hand, 
while vascular invasion is considered as the major 
predictor for distant metastatic spread [12]. Melanoma 
of oral cavity metastasizes early in its course in 
general [1]. Locoregional lymph node metastasis 
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occur in almost half of the cases during first 2 years of 
onset of the disease, while lungs, brain, bones and 
liver involvement affect up to 85% of the patients 
[3][13]. However, early diagnosis and treatment is 
essentially linked to survival rate. Diagnosis is usually 
made, based on the clinical appearance and 
histological findings, which could show a pleomorphic 
pattern that could mimic other tumours such as 
lymphomas, carcinomas, neuroendocrine carcinomas, 
sarcomas, and germ - cell tumours [14][15]. Positive 
inmunohistochemical examination for S – 100, HMB -
45, Melan A, tyrosinase and vimentin is usually helpful 
for confirmation, especially in atypically presented and 
apigmented melanomas [15][16]. However, it is 
postulated that mucosal melanomas may arise not 
only from melanocytes but also from Schwann cells in 
the mucous membrane [17]. The loss of 
heterozygosity at 12p13 and loss of p27K1P1 protein 
expression contribute to melanoma progression 
[17][18]. Surgery is the first choice of treatment, 
requiring collaboration with a maxillofacial specialist 
for reconstruction of the defect [19]. Carbon - ion 
radiotherapy is reported as an effective treatment 
option with acceptable toxicity in oral cavity’s 
melanoma [20]. 
With the presented case, we want to 
emphasize the importance of the early detection and 
accurate diagnosis of melanoma of oral cavity, to its 
influence of the therapeutic outcome. 
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